• Home
  • About
    • Corporate
    • Board
    • Management
  • R & D
    • Pipeline
    • Diabetes
    • Obesity
    • Gene Expression Signature Platform
  • Investors
    • Public Disclosure Policy
    • News & Articles
    • Notices and Reports
    • Scientific Publications & Presentations
    • Subscribe
  • Contact

Notices and Reports

Annual Reports & Financials

Verva Pharmaceuticals 2010 Annual Report-Updated

Verva Pharmaceuticals 2009 Annual Report

 Verva Pharmaceuticals 2008 Annual Report
 

Meetings

Verva 2011 AGM Chairman’s Report

Verva 2011 AGM CEO Report

Verva 2011 AGM Notice

Verva 2010 AGM Notice

Verva 2010 AGM Chairman’s Report

Verva 2010 AGM CEO Report

Verva 2009 AGM Notice

Verva 2009 AGM Booklet

Verva 2009 AGM Proxy

Verva 2009 AGM CEO Report

Verva 2009 AGM Chairman’s Report

 

Presentations

Verva Overview Presentation May 2011

 

Shareholder Communications

2011

Verva Newsletter October 2011

2010

Verva Share Price 30 June 2010

Verva Newsletter December 2010

Verva Consent to Electronic Communication

2009

Verva Buyback Letter 06Nov09

Verva Buyback Q&A 06Nov09

2008

Verva Newsletter April 2008

      Investors

    • Public Disclosure Policy
    • News & Articles
    • Notices and Reports
    • Scientific Publications & Presentations
    • Subscribe
  • Recent News

    • Investment in Verva by the Medical Research Commercialisation Fund (MRCF)
    • Verva Announces AUD 2M Financing and Results of Annual General Meeting
  • Subscribe
  • Contact